Medical equipment industry
MEDTRONIC, a leading healthcare technology company, has been assigned a patent for its design of an electronic package and implantable medical device. The patent, number US 12082354 B2, was originally filed on January 12, 2022. The innovative design of the electronic package and medical device is attributed to four inventors:
Cybernet Data Systems Inc.
Antares Pharma, Inc., a specialty pharmaceutical company, reported its first quarter 2021 financial results on May 6, 2021, showcasing strong revenue growth and profitability. The company's total revenue reached $42.1 million, a 27% increase compared to the same period in 2020. This growth was driven primarily by
Cybernet Data Systems Inc.
Daxor Corporation, the global leader in blood volume measurement technology, has announced the initiation of a multi-center clinical trial with two Veterans Affairs Medical Centers to evaluate Blood Volume Analysis-guided management of acute decompensated heart failure (ADHF) utilizing the BVA-100 blood test. This trial aims to determine the benefit of
United States. Securities and Exchange Commission
Harvard Bioscience Inc., a leading manufacturer of laboratory equipment and instruments, has submitted a filing with the U.S. Securities and Exchange Commission (SEC) reporting a material event. The company, listed under SIC code 3826, has provided detailed information about the occurrence, which is of importance to investors and security
United States. Securities and Exchange Commission
On October 30, 2015, Boston Scientific Corp. submitted a Form 4 filing to the U.S. Securities and Exchange Commission (SEC), revealing insights into the company's ownership structure and transactions. This filing, made possible by the SEC's regulations under Section 12 of the Securities Exchange Act
United States. Securities and Exchange Commission
Spectranetics Corp. has disclosed material events and corporate changes to investors and security holders, according to a U.S. Securities and Exchange Commission (SEC) filing. The company, specializing in Electromedical and Electrotherapeutic Apparatus, has submitted a Form 8-K report, which provides more current information on certain specified events than would
United States. Securities and Exchange Commission
Spectranetics Corp., a company that specializes in electromedical and electrotherapeutic apparatus, has recently submitted a filing to the U.S. Securities and Exchange Commission (SEC). The filing, made on September 30, 2015, discloses changes in the company's ownership and financial information. As a publicly-traded company, Spectranetics Corp. is
United States. Securities and Exchange Commission
Boston Scientific Corp., a leading global medical technology company, has filed a significant report with the U.S. Securities and Exchange Commission (SEC) on October 5, 2015. The company's SEC filing, identifying itself with the SIC code 3841 for Surgical and Medical Instruments and Apparatus, outlines material corporate
United States. Securities and Exchange Commission
Zimmer Biomet Holdings, Inc. has filed a SEC filing (Form SC 13G) with the U.S. Securities and Exchange Commission (SEC) on August 7, 2015. The document was posted on August 24, 2015, and pertains to the company's acquisition of securities in the ordinary course of business, without
United States. Securities and Exchange Commission
Celsion Corp. has fulfilled its regulatory obligations by submitting a Form 4 filing with the U.S. Securities and Exchange Commission (SEC). This filing is a mandatory requirement for companies, as per the guidelines set forth in the Securities Exchange Act of 1934. The submission on August 7, 2015, marks
Health care industry
The health care sector is experiencing mixed trading on Monday, August 17, 2015, with some companies pushing the sector lower and others pushing it higher. The Dow Jones Industrial Average is trading up 56 points (0.3%) at 17,533 as of 12:55 PM ET, with the NYSE advances/
Health care industry
GE Healthcare, a US-based medical technology company, has become the first to receive clearance from the US FDA for its low dose computed tomography (CT) lung cancer screening option. This clearance enables physicians to use the company's CT scanners, specifically those with 64-slice or greater models, for annual
